China Biologic Products Inc. (NASDAQ:CBPO)

Monday, September 19, 2016 | Web News
BEIJING, September 19, 2016 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "...
Monday, June 13, 2016 | Web News
ITEM 7.01. REGULATION FD DISCLOSURE. On June 8, 2016, China Biologic Products, Inc. (the “Company&#...
Monday, June 6, 2016 | Web News
ITEM 1.01 Entry into a Material Definitive Agreement. On June 2, 2016, China Biologic Products, Inc. (the “...

At least one FIE exists in the corporate structure

China Biologic Products, Inc., through its indirect majority-owned subsidiary, Shandong Taibang, is currently the only plasma-based biopharmaceutical company approved by the government of Shandong Province, the second largest province with a population of 93 million. The company is engaged primarily in research, manufacturing, and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China.

Web site:

Last updated March 17, 2008